<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03957395</url>
  </required_header>
  <id_info>
    <org_study_id>JBUH-NN-SCS-2018</org_study_id>
    <nct_id>NCT03957395</nct_id>
  </id_info>
  <brief_title>Comparison of Effectiveness of Tonic, High Frequency and Burst Spinal Cord Stimulation in Chronic Pain Syndromes</brief_title>
  <official_title>Comparison of Effectiveness of Tonic, High Frequency and Burst Spinal Cord Stimulation in Chronic Pain Syndromes: a Double-blind, Randomised, Cross-over, Placebo Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jan Biziel University Hospital No 2 in Bydgoszcz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Jan Biziel University Hospital No 2 in Bydgoszcz</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Spinal cord stimulation (SCS) is one of the most commonly undertaken neuromodulatory surgery
      techniques in the treatment of neuropathic pain. The indication for SCS is an ineffective
      conservative treatment of chronic pain syndromes. The effectiveness of SCS in the case of
      neuropathic pain is high. The positive result of SCS treatment is the reduction of previous
      painful symptoms by min. 50% and / or a reduction in the amount of taken analgesics and an
      improvement in the quality of life including sleep quality. Long-term studies estimate that
      in a properly selected group of patients more than 50% of patients achieve pain reduction by
      the required 50% and about 60% - 70% have an improvement in the quality of life and a
      reduction of pain.

      The efficacy of SCS in different modes of stimulation is evaluated. Patients receive four
      different types of stimulation for 2-week period - not knowing what kind of stimulation it
      is. It is said that in one type of stimulation they would feel parestesias and in other three
      they would not. Patients are not informed that beside tonic, burst and high frequency
      stimulation, the fourth is an off stimulation to check for placebo effect. The test is
      double-blinded
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with FBSS and CRPS are evaluated for VAS,, dissability scale, Quality of Life (QoL),
      sleep disorders and mental disorders.

      All patients undergo percutaneus (1 or 2) 8-contact SCS electrode implantation with trial.

      All patients are blindly randomized to tonic or burst or high frequency or off stimulation.
      After 2-week period each participant is adequately switched to another type of stimulation
      for next 2 weeks. Alltogether crossover takes 8 weeks: four 2-week periods of tonic, burst,
      HF and off stimulation. At the end of trial period patients are subjected to the mode of
      stimulation which is the most efficent. The final 2-week stimulation is performed with final
      renewed evaluation for VAS, amount of taken medications, dissability scale, Quality of Life
      (QoL), sleep disorders and mental disorders. Follow-up observation will last up to 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline in VAS for back and leg pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oswestry Disability Index</measure>
    <time_frame>12 months</time_frame>
    <description>Change from baseline in functionality using the ODI score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>12 months</time_frame>
    <description>Number of AE through the study</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of pain medication</measure>
    <time_frame>12months</time_frame>
    <description>List of pain medication taken by patient</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life scale</measure>
    <time_frame>12months</time_frame>
    <description>Quality of life assessed by EuroQol group - 5 Dimensions (EQ-5D)</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Failed Back Surgery Syndrome</condition>
  <condition>CRPS (Complex Regional Pain Syndromes)</condition>
  <arm_group>
    <arm_group_label>scs high-frequency</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high-frequency stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scs tonic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>tonic stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scs burst</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>burst stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>scs off</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>off stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device: Precision Novi™ system Neurostimulation procedures</intervention_name>
    <description>SCS with Device: Precision Novi™ system</description>
    <arm_group_label>scs burst</arm_group_label>
    <arm_group_label>scs high-frequency</arm_group_label>
    <arm_group_label>scs off</arm_group_label>
    <arm_group_label>scs tonic</arm_group_label>
    <other_name>SCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. FBSS, CRPS patients with neuropathic and mixed pain in low-back and/or legs refractory
             to conservative therapy

          2. Chronic pain as a result of FBSS that exists for at least 6 months

          3. ≥ 18 years of age

          4. Written consent of the patient to participate in study procedures.

        Exclusion Criteria:

          1. Active malignancy

          2. Addiction to any of the following: drugs, alcohol and/or medication

          3. Evidence of an active disruptive psychiatric disorder or other known condition
             significant enough to impact perception of pain, compliance to intervention and/or
             ability to evaluate treatment outcome as determined by investigator

          4. Local infection or other skin disorder at site of surgical incision

          5. Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paweł Sokal</last_name>
    <role>Principal Investigator</role>
    <affiliation>Jan Biziel University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pawel Sokal, Ph.D.</last_name>
    <phone>+48600954415</phone>
    <email>pawel.sokal@cm.umk.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Neurosurgery and Neurology University Hospital nr 2 Collegium Medicum Nicolaus Copernicus University</name>
      <address>
        <city>Bydgoszcz</city>
        <zip>85-168</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paweł Sokal, Ph.D.</last_name>
      <phone>+48600954415</phone>
      <email>pawel.sokal@cm.umk.pl</email>
    </contact>
    <contact_backup>
      <last_name>Agnieszka Malukiewicz, M.D.</last_name>
      <phone>+48 604 892 763‬</phone>
      <email>agnieszka.malukiewicz@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Agnieszka Malukiewicz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 17, 2019</study_first_submitted>
  <study_first_submitted_qc>May 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2019</study_first_posted>
  <last_update_submitted>May 27, 2019</last_update_submitted>
  <last_update_submitted_qc>May 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jan Biziel University Hospital No 2 in Bydgoszcz</investigator_affiliation>
    <investigator_full_name>Pawel Sokal</investigator_full_name>
    <investigator_title>Head of Department of Neurosurgery and Neurology</investigator_title>
  </responsible_party>
  <keyword>FBSS</keyword>
  <keyword>CRPS</keyword>
  <keyword>SCS</keyword>
  <keyword>Burst</keyword>
  <keyword>Tonic</keyword>
  <keyword>High-frequency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Complex Regional Pain Syndromes</mesh_term>
    <mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Failed Back Surgery Syndrome</mesh_term>
    <mesh_term>Somatoform Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

